Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

15th Asia Pacific Oncologists Annual Meeting

Tokyo, Japan

Jae Pil Hwang

Jae Pil Hwang

Soonchunhyang University Hospital, Korea

Title: Introduction and clinical application of PET/CT for oncologists

Biography

Biography: Jae Pil Hwang

Abstract

In recent decades, 18F–fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is non-invasive imaging modality and has been routinely used for diagnosis, staging, restaging, assessing treatment response, detecting recurrence after treatment and evaluating prognosis of patients in various malignancies.

Because tumor FDG uptake is associated with tumor aggressiveness, positive tumor FDG uptake on visual analysis and intensity of uptake, expressed as maximum standardized uptake value (SUVmax), volumetric parameters including metabolic tumor volume (MTV), total lesion glycolysis (TLG) and intratumoral heterogeneity reflecting the biological tumor conditions such as metabolism, hypoxia, necrosis, and cellular proliferation.

In this forum, we overview the introduction and clinical applications of oncologic PET/CT that investigated metabolic characteristics on various cancers, and we discuss the clinical roles of PET/CT for patients with malignant disease and for clinical oncologists. Although FDG continues to be the most widely used radiotracer for PET imaging, some of the another or newer PET imaging agents that have been studied in humans will also be announced